Medtronic formally launched ViaVerte at ASPN 2026, with its $650m acquisition of SPR Therapeutics completing at the meeting’s outset on 16 July.

The post Medtronic continues assembly of industry’s “broadest” pain therapy portfolio appeared first on Medical Device Network.